That's OncoIntelligenceTM.
Learn More About PreciseBreast
Traditional tumor grading in breast cancer can be subjective, resulting in a high percentage of patients being classified with Intermediate/Grade 2 tumors even though many are low risk. As a result, patients must wait 2-6 weeks for costly gene expression test results, ultimately delaying vital care planning.
65%
Intra-observer variations in grading results***
56%
of Grade 3 tumors are low risk**
22%
of Grade 2 tumors are high risk**
78%
of Grade 2 tumors are low risk**
*Sparano, New England Journal of Medicine. 2018
**Based on a retrospective longitudinal study of more than 2,000 cancer cases. Fernandez, G., Prastawa, M., Madduri, A.S. et al. Breast Cancer Research 2022’.
***Paik, New England Journal of Medicine, 2004
The current standard
While gene expression testing adds significantly to the information provided by tumor grading, it can take up to six weeks to complete and costs more than $4,000. And because it’s used primarily with excisional specimens, it requires significant time and labor of the pathology department. Even then, gene expression testing may still rely on subjective tumor grading in its risk score, and the limited reporting features can lead to clinical ambiguity.
See More
Our Solution
PreciseBreast deploys OncoIntelligenceTM to visually analyze the cellular morphology of tissue samples already collected – the same slides pathologists use for tumor grading.
OncoIntelligence visually inspects every cell on the slide to ensure accurate, quantitative data that reliably identifies recurrence risk.
The results
PreciseBreast provides objective and reliable risk stratification in hours, allowing oncologists to confidently discuss results, in days, rather than weeks, to relieve patient anxiety and to allow for a more comprehensive shared decision-making process.
That is what we call OncoIntelligenceTM.
PreciseBreast powers the process of diagnosis and cancer care planning for everyone.
Medical society partners
We are proud to work with some of the most important cancer associations and societies.
.png)
Please fill out the form below.
